Pel-Freez Makes Alliance

Pel-Freez Clinical Systems, a division of Rogers-based Pel-Freez Inc., and The Anthony Nolan Bone Marrow Trust of London, England, have initiated a long-term strategic alliance for the development, production and marketing of new methods and procedures to benefit patients with various diseases treatable by bone marrow transplants.

The new agreement gives Pel-Freez exclusive global rights for nucleic acid-based tissue typing and analysis technologies based on research from The Anthony Nolan Bone Marrow Trust.

The alliance brings together resources from internationally known Anthony Nolan Bone Marrow Trust and Pel-Freez, with its growing global market, to develop relevant technology to benefit transplant patients worldwide.